MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,285,000 | +84.1% | 18,400 | +76.9% | 0.06% | +110.3% |
| Q2 2022 | $698,000 | -68.9% | 10,400 | -18.1% | 0.03% | -69.5% |
| Q3 2021 | $2,247,000 | +93.7% | 12,700 | +76.9% | 0.10% | +97.9% |
| Q2 2021 | $1,160,000 | -24.6% | 7,179 | -20.0% | 0.05% | -23.8% |
| Q1 2021 | $1,539,000 | -35.1% | 8,979 | -16.9% | 0.06% | -30.8% |
| Q4 2020 | $2,372,000 | +119.8% | 10,800 | +66.2% | 0.09% | +78.4% |
| Q3 2020 | $1,079,000 | -41.5% | 6,500 | -72.9% | 0.05% | -65.1% |
| Q1 2020 | $1,845,000 | -34.0% | 24,000 | +10.6% | 0.15% | -5.8% |
| Q4 2019 | $2,797,000 | – | 21,700 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |